The immunogenicity of dendritic cell-derived exosomes

被引:126
|
作者
Quah, BJC [1 ]
O'Neill, HC [1 ]
机构
[1] Australian Natl Univ, Sch Biochem & Mol Biol, Canberra, ACT 0200, Australia
基金
英国医学研究理事会;
关键词
exosomes; dendritic cells; T cell activation; tumour immunity;
D O I
10.1016/j.bcmd.2005.05.002
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Exosome production represents an alternate endocytic pathway for secretion. Multivesicular endosomes (MVE) fuse with the plasma membrane expelling internal vesicles or exosomes from cells. Exosome production has been recently described for immune cells including B cells, dendritic cells (DC), mast cells, macrophages and T cells. Exosomes derived from some DC populations stimulate T lymphocyte proliferation in vitro and have potent capacity to generate anti-tumour immune responses in vivo. These reported studies have involved in vitro grown mature DC expanded from precursors with cytokines. However, immature DC produce higher numbers of exosomes than mature DC and this is thought to be due to a reduction in endocytosis as DC mature, associated with reduced reformation of MVE and reduced exosome formation. This lab pioneered a method to generate immature DC in spleen long-term cultures (LTC). DC produced in cultures represent immature myeloid DC, highly endocytic but with weak capacity to stimulate T cells. LTC-DC produce exosomes and contain many MVE. This prompted a study of immunogenic potential with a view to the potential use of exosomes in vaccination and immunotherapy. DC produced in cultures represent immature myeloid DC, highly endocytic but with weak capacity to stimulate T cells. Exosomes were isolated by differential centrifugation from LTC-DC and shown by marker expression to arise by budding from the LAMP-1(+) limiting endosomal membrane of MVE. These LTC-derived exosomes appear however to lack immunostimulatory markers like CD86, CD40, MHC-I and MHC-II. While LTC-DC can stimulate antigen-specific proliferation of CD4(+) T cells, exosome preparations derived from antigen-pulsed DC were unable to stimulate purified naive T cells in vitro. They were however found to weakly activate allogeneic CD8(+) T cells in vitro. Tumour antigen-pulsed LTC-DC or their exosomes could induce a protective response in mice against growth of a transplanted tumour but could not induce a response to clear an existing tumour. Exosomes derived from immature DC can modulate immune responses, but do not function in direct T cell activation in vitro. Modulation of immune responses by exosomes produced by immature DC may be dependent on the presence of other antigen presenting DC subsets in the animal. The possible function of immature DC and their exosomes in maintenance of tolerance and in the induction of immunity is discussed. (c) 2005 Elsevier Inc. All rights reserved.
引用
收藏
页码:94 / 110
页数:17
相关论文
共 50 条
  • [11] Dendritic Cell-Derived Exosomes as Immunotherapies in the Fight against Cancer
    Pitt, Jonathan M.
    Charrier, Melinda
    Viaud, Sophie
    Andre, Fabrice
    Besse, Benjamin
    Chaput, Nathalie
    Zitvogel, Laurence
    JOURNAL OF IMMUNOLOGY, 2014, 193 (03): : 1006 - 1011
  • [12] Melanoma cell-derived exosomes alter macrophage and dendritic cell functions in vitro
    Marton, Annamaria
    Vizler, Csaba
    Kusz, Erzsebet
    Temesfoi, Viktoria
    Szathmary, Zsuzsa
    Nagy, Krisztina
    Szegletes, Zsolt
    Varo, Gyorgy
    Siklos, Laszlo
    Katona, Robert L.
    Tubak, Vilmos
    Howard, O. M. Zack
    Duda, Erno
    Minarovits, Janos
    Nagy, Katalin
    Buzas, Krisztina
    IMMUNOLOGY LETTERS, 2012, 148 (01) : 34 - 38
  • [13] Dendritic Cell-Derived Exosomes Stimulate Stronger CD8+ CTL Responses and Antitumor Immunity than Tumor Cell-Derived Exosomes
    Hao, Siguo
    Bai, Ou
    Yuan, Jinying
    Qureshi, Mabood
    Xiang, Jim
    CELLULAR & MOLECULAR IMMUNOLOGY, 2006, 3 (03) : 205 - 211
  • [14] Dendritic Cell-Derived Exosomes Stimulate Stronger CD8~+ CTL Responses and Antitumor Immunity than TVimor Cell-Derived Exosomes
    Mabood Qureshi
    Jim Xiang
    Cellular & Molecular Immunology, 2006, (03) : 205 - 211
  • [15] Immature Dendritic Cell-Derived Exosomes: a Promise Subcellular Vaccine for Autoimmunity
    Yin, Weifan
    Ouyang, Song
    Li, Yi
    Xiao, Bo
    Yang, Huan
    INFLAMMATION, 2013, 36 (01) : 232 - 240
  • [16] Dendritic cell-derived exosomes: A new horizon in personalized cancer immunotherapy?
    Ghorbaninezhad, Farid
    Alemohammad, Hajar
    Najafzadeh, Basira
    Masoumi, Javad
    Shadbad, Mahdi Abdoli
    Shahpouri, Mohammad
    Saeedi, Hossein
    Rahbarfarzam, Omid
    Baradaran, Behzad
    CANCER LETTERS, 2023, 562
  • [17] Immature Dendritic Cell-Derived Exosomes: a Promise Subcellular Vaccine for Autoimmunity
    Weifan Yin
    Song Ouyang
    Yi Li
    Bo Xiao
    Huan Yang
    Inflammation, 2013, 36 : 232 - 240
  • [18] Dendritic Cell-Derived Exosomes for Cancer Immunotherapy: What's Next?
    Viaud, Sophie
    Thery, Clotilde
    Ploix, Stephanie
    Tursz, Thomas
    Lapierre, Valerie
    Lantz, Olivier
    Zitvogel, Laurence
    Chaput, Nathalie
    CANCER RESEARCH, 2010, 70 (04) : 1281 - 1285
  • [19] Improving the immunogenicity of dendritic cell-derived exosome vaccines for the immunotherapy of melanoma
    Damo, Martina
    Wilson, David Scott
    Hubbell, Jeffrey Alan
    CANCER RESEARCH, 2016, 76
  • [20] Dendritic cell-derived exosomes as cell-free peptide-based vaccines
    Taïeb, J
    Chaput, N
    Zitvogel, L
    CRITICAL REVIEWS IN IMMUNOLOGY, 2005, 25 (03) : 215 - 223